Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma

Thoracic and Cardiovascular Surgeon

Volumn 58, Issue 4, 2010, Pages 215-219

  Pilling, J ^a   Dartnell, J A ^a   Lang Lazdunski, L ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Computed tomography; Mediastinal lymph nodes; Mesothelioma; Positron emission tomography (PET); Staging

Indexed keywords

ANTINEOPLASTIC AGENT;

ACCURACY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMAGE RECONSTRUCTION; LUNG RESECTION; MALE; MALIGNANT MESOTHELIOMA; MEDIASTINUM DISEASE; MULTIMODALITY CANCER THERAPY; PLEURA MESOTHELIOMA; PLEURODESIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THORAX DISEASE; TUMOR BIOPSY;

AGED; BIOPSY; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODE EXCISION; MALE; MEDIASTINOSCOPY; MESOTHELIOMA; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PLEURAL NEOPLASMS; PLEURODESIS; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TALC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77953149274     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0029-1241029     Document Type: Article

References (22)

1. Sugarbaker D J., Flores R M., Jaklitsch M T., Richards W G., Strauss G M., Corson J M. et al. Resection margins, extrapleural nodal status and cell type determine postoperative long term survival in trimodality therapy of malignant pleural mesothelioma: results of 183 patients. J Thorac Cardiovasc Surg 1999 117 54-65
2. Edwards J, Abrams K R., Leverment J N., Spyt T J., Waller D A., O'Byrne K J. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 2000 55 731-735
3. Pilling J E., Nicholson A G., Harmer C, Goldstraw P. Prolonged survival due to spontaneous regression and surgical excision of malignant mesothelioma. Ann Thorac Surg 2007 83 314-315
4. Pilling J E., Stewart D J., Martin-Ucar A E., Muller S, O'Byrne K J., Waller D A. The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg 2004 25 497-501
5. Treasure T, Tan C, Lang-Lazdunski L, Waller D. The MARS trial: mesothelioma and radical surgery. Interact Cardiovasc Thorac Surg 2006 5 58-89
6. Rusch V W. A proposed new international TNM staging system for malignant pleural mesothelioma. From the international mesothelioma interest group. Chest 1995 108 1122-1128
7. Wang Z J., Reddy G P., Gotway M B., Higgins C B., Jablons D M., Ramaswamy M, Hawkins R A., Webb W R. Malignant pleural mesothelioma: evaluation with CT, MR imaging and PET. RadioGraphics 2004 24 105-119
8. Benard F, Sterman D, Smith R J., Kaiser L R., Albeda S M., Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest 1998 114 713-722
9. Flores R M., Akhurst T, Gonen M, Zakowski M, Dycoco J, Larsen S M., Rusch V W. Positron emission tomography predicts survival in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2006 132 763-768
10. Patz Jr E F., Shaffer K, Piwnica-Worms D R. et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting respectability. Am J Roentgenol 1992 159 961-966
11. Stewart D J., Waller D, Edwards J, Jeyapalan K, Entwistle J. Is there a role for pre-operative contrast-enhanced magnetic resonance imaging for radical surgery in malignant pleural mesothelioma? Eur J Cardiothorac Surg 2003 24 1019-1024
12. Flores R M., Akhurst T, Gonen M, Larsen S M., Rusch V W. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2003 126 11-15
13. Erasmus J J., Troung M T., Smythe W R., Munden R F., Marom E M., Rice D C., Vaporciyan A A., Walsh G L., Sabloff B S., Broemeling L D., Stevens C W., Pisters K M., Podoloff D A., Macapinlac H A. Integrated computed tomography positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications. J Thorac Cardiovasc Surg 2005 129 1364-1370
14. Rice D C., Erasmus J J., Stevens C W., Vaporciyan A A., Wu J S., Tsao A S., Walsh G L., Swisher S G., Hofstetter W L., Ordonez N G., Smythe W R. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg 2005 80 1988-1992
15. Flores R, Krug L, Rosenzweig K, Venkatraman E, Vincent A, Heelan R, Akhurst T, Rusch V. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Onc 2006 1 (4) 289-295
16. Schneider D B., Clay-Macy C, Challa S, Sasse K C., Merrick S H., Hawkins R, Caputo G, Jablons D. Positron emission tomography with F18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2000 120 128-133
17. Graham A N., Chan K J., Pastorino U, Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 1999 117 246-251
18. Gerbaudo V H., Sugarbaker D J., Britz-Cunningham S, Di Carli M F., Mauceri C, Treves S T. Assessment of malignant pleural mesothelioma with 18F-FDG dual-head gamma camera coincidence imaging: comparison with histopahology. J Nuc Med 2002 43 1144-1149
19. Merritt N, Blewett C J., Miller J D., Bennett W F., Young J E., Urschel J D. Survival after conservative (palliative) management of pleural malignant mesothelioma. J Surg Oncol 2001 78 171-174
20. Francis R J., Byrne M J., van der Schaaf A A. et al. Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume based analysis of serial 18F-FDG PET scans. J Nucl Med 2007 48 1449-1458
21. Ceresoli G L., Chiti A, Zucali P A. et al. Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18]fluorodeoxyglucose. J Clin Oncol 2006 24 4587-4593
22. Weber W A. Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 2005 46 983-995